ClinicalTrials.Veeva

Menu

Evaluating Violence Against Women Screening in Mexico

Yale University logo

Yale University

Status

Completed

Conditions

Domestic Violence

Treatments

Behavioral: Integrated Screening

Study type

Interventional

Funder types

Other

Identifiers

NCT01661504
1202009793

Details and patient eligibility

About

The overall goal of this proposed study is to develop the state of knowledge in the area of gender-based violence and reproductive health by conducting a randomized controlled trial to improve the health care provider's capacity to screen for intimate partner violence and to mitigate associated risk among women health clinic patrons of reproductive age (ages18-44) with recent experiences of physical or sexual partner violence in Mexico City and its surrounding area.

The specific research objectives are as follows:

  1. To increase mid-level health care providers' capacity to identify Intimate Partner Violence (IPV) and assist women with risk mitigation
  2. Utilizing a randomized controlled trial, to assess the impact of an enhanced health care worker screening and counselling program on (a) past year severe IPV (sexual or physical), including severe IPV; (b) reproductive coercion (c) use of community-based resources and safety planning; and (d) quality of life; versus minimum standard of care
  3. To qualitatively examine which programmatic components may serve as mechanisms for observed changes stated in the second objective
  4. To synthesize study findings and a) create recommendations for clinic-based intervention programs to address IPV in low and middle income countries and b) disseminate information as reports, presentation, and peer-reviewed publications

Enrollment

959 patients

Sex

Female

Ages

18 to 44 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Ages 18-44
  • Currently in heterosexual relationship with a male partner
  • Responds in affirmative to past year sexual or physical violence

Exclusion criteria

  • Cognitive impairment (slurred speech, inability to follow directions)
  • Seeking treatment for life threatening emergency care
  • Intends to relocate within 2 years.

Trial design

Primary purpose

Screening

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

959 participants in 2 patient groups

Referral Card Only
No Intervention group
Description:
Women participants at control clinics will be given a referral card containing general information on IPV and a list of resources specific to their community
Integrated Screening
Experimental group
Description:
The intervention arm will consist of the following components (described in detail below): a) integrated IPV/Sexual and Reproductive Health Screening, b) supportive care, c) safety planning and harm reduction counseling, d) supported referrals, e) booster counseling sessions at 3 months post-baseline / initial counseling
Treatment:
Behavioral: Integrated Screening

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems